|
|
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity |
| 5 R01 AG066750-02 |
|
NIA |
2021 |
|
|
24-hour Activity Cycles to Optimize Cognitive Resilience to Alzheimers Disease in African Americans: The Jackson Heart Study |
| 5 R01 AG067513-02 |
|
NIA |
2021 |
|
|
Personality prediction of dementia risk and progression |
| 5 R01 AG067622-03 |
|
NIA |
2021 |
|
|
Statistical Models of Alzheimer's Disease Pathological Cascade |
| 5 R01 AG068002-02 |
|
NIA |
2021 |
|
|
Circadian Organization and Disorder in Alzheimer's Disease |
| 5 R01 AG068577-02 |
|
NIA |
2021 |
|
|
Reconstructing the temporal landscape of gene regulation in aging |
| 5 R01 AG068579-02 |
|
NIA |
2021 |
|
|
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease |
| 5 R01 AG070487-02 |
|
NIA |
2021 |
|
|
Polypharmacy, Potentially Inappropriate Medications, and Adverse Outcomes in Older Adults with Advanced Cancer Receiving Chemotherapy |
| 5 R03 AG067977-02 |
|
NIA |
2021 |
|
|
The Effects of Cognitive Map Building on the Development of Alzheimers Disease |
| 5 R21 AG069267-02 |
|
NIA |
2021 |
|
|
Clarifying the relationship between delirium and Alzheimers Disease and related |
| 5 R33 AG057979-04 |
|
NIA |
2021 |
